Research
Metabolic adaptation
Semaglutide treatment led to larger reductions in glycated hemoglobin levels compared to the control group (−1.3% vs. −0.6%; P <0.001).
Semaglutide may improve glycemic control in patients post-ablation.
StrongSupportsmedium confidence
During the 12-month follow-up, the semaglutide group showed larger reductions in glycated hemoglobin (−1.3% [0.8] versus −0.6% [0.8]; P <0.001).
Why this rating
The study is a prospective cohort with a significant sample size.
Source
Effect of Semaglutide on Atrial Arrhythmias Recurrence Following Ablation for Atrial Fibrillation: A Prospective Study
Jiongchao Guo et al. · Circulation Arrhythmia and Electrophysiology · 2025
cohort · n=437Cited 6×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →